Literature DB >> 9704479

The French haemovigilance system.

L Noel1, J Debeir, A Cosson.   

Abstract

Haemovigilance was part of the reform of the French transfusion system. The haemovigilance network is now operational with approximately 4600 transfusion incidents reported annually. Immediate incidents observed within 8 days after transfusion account for 85% of the reports. A cause cannot be identified in 41% of these, usually concerning minor clinical incidents with transient fever and/or shivers. An allergic reaction is described in 31% of transfusion reactions. Immunological conflicts account for 18% and bacteria associated transfusion reactions for 6%. The importance of bacteria associated transfusion reactions, the first identified cause of death associated with transfusion is one of the findings of haemovigilance. Improvement in the haemovigilance systems aims at obtaining better descriptions of transfusion incidents, standardisation of severity and imputability assessment and definitions of denominators such as the actual number of recipients. Delayed incidents will ultimately provide a true vision of post transfusion immunisation and infection The improvement of haemovigilance now considered as part of transfusion medicine practice is a continuous process.

Entities:  

Mesh:

Year:  1998        PMID: 9704479     DOI: 10.1111/j.1423-0410.1998.tb05454.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  3 in total

Review 1.  Haemovigilance: A Current Update in Indian Perspective.

Authors:  Somnath Mukherjee; Rituparna Maiti
Journal:  J Clin Diagn Res       Date:  2016-11-01

2.  Reporting of transfusion reactions in a hospital in Brazil.

Authors:  Francyne Kubaski; Daniéle Sausen Lunkes; Tor Gunnar Hugo Onsten
Journal:  Blood Transfus       Date:  2012-07-04       Impact factor: 3.443

3.  Code development of the national hemovigilance system and expansion strategies for hospital blood banks.

Authors:  Kim Jeongeun; Kim Sukwha; Han Kyusup; Lee Kyungsoon
Journal:  Asian J Transfus Sci       Date:  2012-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.